CNBCBarriers to entering the pharmaceutical industry are too high even for Amazon: Billionaire investorCNBCBarriers into the pharmaceutical business might be too high even for Amazon, said billionaire hedge-fund manager Larry Robbins. Last fall, a report surfaced that the e-commerce giant had obtained wholesale pharmacy licenses in multiple states in an ...Hedge fund billionaire explains why Amazon won't get into pharmaYahoo FinanceGlenview's Robbins says talk of Amazon's entering pharma is overblownReutersAmazon Pharmacy Competition Is Overblown, Larry Robbins Says at SohnBloombergall 7 news articles »